InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Plasmocin® - Mycoplasma Elimination Reagent | The mitophagy receptor NIX induces vIRF-1 oligomerization and interaction wit... | 2023 | PLoS Pathog. | Vo M.T. et al. | DOI: 10.1371/journal.ppat.1011548 |
| Anti-hIL-1β-IgG | IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppre... | 2023 | Nat Commun. | Koncina E. et al. | DOI: 10.1038/s41467-023-39953-w |
| PHA-P | CDK7 controls E2F-and MYC-driven proliferative and metabolic vulnerabilities ... | 2023 | Blood | Yao Y. et al. | DOI: 10.1182/blood.2022018885 |
| PHA-P | Cross‐platform immunophenotyping of human peripheral blood mononuclear cells ... | 2023 | Cytometry A | Heubeck A. et al. | DOI: 10.1002/cyto.a.24715 |
| PHA-P | Discovery of novel resorcinol biphenyl ether-based macrocyclic small molecule... | 2023 | Bioorg Chem. | Yang Z. et al. | DOI: 10.1016/j.bioorg.2023.106740 |
| G418 (Geneticin) | Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines a... | 2023 | Signal Transduct Target Ther. | Gu Y. et al. | DOI: 10.1038/s41392-023-01479-4 |
| Imiquimod (R837) | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
| ODN 1826 - TLR9 ligand | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
| HEK-Blue™ Detection | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
| LPS-EB (LPS from E. coli O111:B4) | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
| Pam3CSK4 | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
| Pam2CSK4 | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
| QUANTI-Blue™ | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
| ASC-GFP Reporter Monocytes | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
| QUANTI-Luc™: Luciferase Detection Reagent | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
| TLR4 KO Dual Reporter THP-1 Cells | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
| THP1-defCASP1 Cells | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
| LPS-EK (LPS from E. coli K12) | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
| NLRP3 KO & KD THP-1 Cells | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |